Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company and an unconsolidated or other off balance sheet entity that would be reasonably likely to have a Material Adverse Effect.
Appears in 12 contracts
Sources: Securities Purchase Agreement (Vallon Pharmaceuticals, Inc.), Securities Purchase Agreement (Acurx Pharmaceuticals, LLC), Securities Purchase Agreement (Cellect Biotechnology Ltd.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that would be reasonably likely to have a Material Adverse Effect.
Appears in 6 contracts
Sources: Securities Purchase Agreement (REZOLVE AI LTD), Securities Purchase Agreement (Critical Metals Corp.), Securities Purchase Agreement (Global Technologies LTD)
Off-Balance Sheet Arrangements. There is no agreement, commitment, transaction, arrangement, or other relationship between the Company (or any of its Subsidiaries) and an any unconsolidated or other off balance sheet entity that would have or reasonably be reasonably likely expected to have a Material Adverse Effect.
Appears in 5 contracts
Sources: Securities Purchase Agreement (Origin Bancorp, Inc.), Securities Purchase Agreement (Origin Bancorp, Inc.), Securities Purchase Agreement (Origin Bancorp, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any of its Subsidiaries) and an unconsolidated or other off balance sheet entity that would have or reasonably be reasonably likely expected to have a Material Adverse Effect.
Appears in 3 contracts
Sources: Securities Purchase Agreement (First NBC Bank Holding Co), Securities Purchase Agreement (First NBC Bank Holding Co), Securities Purchase Agreement (First NBC Bank Holding Co)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or its Subsidiary and an unconsolidated or other off balance sheet entity that would could be reasonably likely to have a Material Adverse Effect.
Appears in 3 contracts
Sources: Securities Purchase Agreement (Investview, Inc.), Securities Purchase Agreement (PV Nano Cell, Ltd.), Securities Purchase Agreement (PV Nano Cell, Ltd.)
Off-Balance Sheet Arrangements. There is no material transaction, arrangement, or other relationship between the Company and an unconsolidated or other off balance sheet entity that would be reasonably likely to have a Material Adverse Effectentity.
Appears in 3 contracts
Sources: Placement Agency Agreement (Prime Meridian Holding Co), Placement Agent Agreement (First Colebrook Bancorp, Inc.), Placement Agent Agreement (First Colebrook Bancorp, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company and an unconsolidated or other off balance sheet entity that would have or reasonably be reasonably likely expected to have result in, individually or in the aggregate, a Material Adverse Effect.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Entasis Therapeutics Holdings Inc.), Securities Purchase Agreement (Innoviva, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its subsidiaries and an unconsolidated or other off balance sheet entity that would is not disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Lm Funding America, Inc.), Stock Purchase Agreement (Lm Funding America, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company and an unconsolidated or other off balance sheet entity that has not been disclosed to Purchaser or that otherwise would reasonably be reasonably likely expected to have a Material Adverse Effect.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that would have or reasonably be reasonably likely expected to have a Material Adverse Effect.
Appears in 1 contract
Sources: Securities Purchase Agreement (Bankwell Financial Group, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or the Bank) and an unconsolidated or other off balance sheet entity that would have or reasonably be reasonably likely expected to have a Material Adverse Effect.
Appears in 1 contract
Sources: Securities Purchase Agreement (Grandsouth Bancorporation)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company and an unconsolidated or other off balance sheet entity not disclosed in the Financial Statements or that otherwise would be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company and an unconsolidated or other off balance sheet entity that is not disclosed by the Company in its Financial Statements or the Interim Financial Statements or that otherwise would be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
Sources: Securities Purchase Agreement (OWC Pharmaceutical Research Corp.)